DSIP (Delta Sleep-Inducing Peptide) Research Evidence
The DSIP (Delta Sleep-Inducing Peptide) evidence base: trials, journals, and what the data does not yet show.
Dated, Limited Human Data
Much of the foundational DSIP research dates to the 1970s-1990s, predating modern clinical trial standards. Some small human studies explored effects on sleep architecture and stress hormones, but the evidence base is thin and outdated by current standards, with no large modern randomized controlled trial.
Regulatory and Legal Status
DSIP has no FDA-approved indication and is not approved for human consumption. It is sold exclusively as a research-grade compound (RUO). Researchers and users should verify the legal status of DSIP in their jurisdiction prior to purchase or use.
References
- Effects of Delta Sleep-Inducing Peptide on Sleep of Chronic Insomniac Patients: A Double-Blind Study · Schneider-Helmert D, Schoenenberger GA · 1992